article thumbnail

FDA Releases Plan To Obtain Data Regarding Cannabis-Derived Product Usage & Safety

Cannabis Law Report

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”

Safety 52
article thumbnail

Smartphone Sensor Data Could Detect Cannabis Intoxication With 90% Precision

Veriheal

A brand new study featured in the journal Drug and Alcohol Dependence delivered exciting news to psychiatrists, health professionals, and law enforcement officials across the United States and beyond. The investigation assessed the suitability of using smartphone sensor data to detect cannabis intoxication, and it had promising results.

Data 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Data Analysis Yields Insights Into Medical Cannabis Use, Efficacy

Cannabis Law Report

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.

Data 105
article thumbnail

Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

Cannabis Law Report

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The primary endpoint of our Phase 1 clinical trial was to test and demonstrate safety and tolerability.

article thumbnail

Does Legal Cannabis Increase Your Home’s Value? This Data Says So

Cannabis Law Report

According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Administrative costs of initiating new laws. General funds.

Data 116
article thumbnail

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

Cannabis Law Report

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. Forward-Looking Statements.

Data 100
article thumbnail

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.

Safety 52